Jaka jest cena za NanoVibronix, Inc. (NAOV)

Cena za NanoVibronix, Inc. (NAOV) wynosi $1.90

Jaka jest kapitalizacja rynkowa dla NanoVibronix, Inc. (NAOV)

Kapitalizacja rynkowa dla NanoVibronix, Inc. (NAOV) wynosi $1.51M

NanoVibronix, Inc. (NAOV) Wskaźnik C/Z

NanoVibronix, Inc., operating through its subsidiary NanoVibronix Ltd., develops and commercializes innovative, non-invasive devices that stimulate biological responses for therapeutic purposes. Their core focus areas include mitigating biofilm formation, accelerating wound repair, and alleviating pain. Key among their product line is UroShield, an ultrasound-based solution engineered to deter bacterial colonization and biofilm development in urinary catheters, thereby boosting antibiotic efficacy and reducing associated patient discomfort. They also offer PainShield and WoundShield, both patch-based therapeutic ultrasound technologies. PainShield targets relief from pain, muscle spasms, and joint contractures, while WoundShield is designed to foster tissue regeneration and promote healing in wounds. The company distributes these products directly to consumers and via extensive distributor networks spanning the United States, Israel, Europe, India, and numerous other international regions. Founded in 2003, NanoVibronix, Inc. maintains its corporate headquarters in Elmsford, New York.

Rok	Wskaźnik P/E	Zmień
Za mało danych dla podanych dat.

Rok

Wskaźnik P/E

Zmień

Za mało danych dla podanych dat.

Firma	Wskaźnik P/E	Różnica wskaźnika P/E	Kraj
Abbott Laboratories ABT.US	33.99	-	US
Stryker Corporation SYK.US	33.47	-	US
Medtronic plc MDT.US	21.39	-	IE
Boston Scientific Corporation BSX.US	18.84	-	US
Edwards Lifesciences Corporation EW.US	49.47	-	US

Firma

Wskaźnik P/E

Różnica wskaźnika P/E

Kraj